Market Overview

Global Bi-Specific Antibodies Market Forecast to 2022 - Increasing Demand for Bi-Specific/Double Barreled Antibodies - ResearchAndMarkets.com

Share:

The "Global
Bi-Specific Antibodies Market Forecast to 2022"
report has been
added to ResearchAndMarkets.com's offering.

According to the report, the Global Bi-Specific Antibodies Market is
anticipated to witness a double digit growth during the forecast period.

In this report, we have structured the information regarding bi-specific
antibodies at various stages of clinical development. The pipeline
chapter provides in depth analysis of bi-specific antibodies by clinical
phase, indications for which they are being developed, and technology.

Additionally, the study provides all-inclusive current analysis of
various bi-specific antibodies in advanced as well as early stages of
development. Moreover, the report places emphasis on the strategic
collaborations that can impact industry's growth.

The prominent players in Global Bi-Specific Antibodies Market have been
discussed in the last section of the report. A brief business overview
and financial information about each of these players has been provided,
along with their product portfolios, product pipeline and recent
developments.

Overall, the research contains exhaustive information that will help
clients in formulating market strategies and assessing opportunity areas
in the Global Bi-Specific Antibodies Market.

Market Dynamics

Drivers

  • Rising Global Cancer Epidemics
  • Bi-Specific Antibodies Improving the Targeting Capabilities of
    Traditional mAbs
  • T-cells in Bi-Specific Antibodies Mediated Immunotherapy
  • Increasing Demand for Bi-Specific/Double Barreled Antibodies

Challenges

  • Production Hurdles in Bi-Specific Antibodies Development
  • Regulatory Challenges

Companies Featured

  • AbbVie Inc.
  • Amgen Inc.
  • Aptevo Therapeutics Inc.
  • F. Hoffman La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Glenmark Pharmaceuticals Limited
  • Ligand Pharmaceuticals, Inc.
  • MacroGenics, Inc.
  • Merus N.V.
  • OncoMed Pharmaceuticals, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Xencor, Inc.

Key Topics Covered

1. Analyst View

2. Research Methodology

3. Bi-Specific Antibodies - An Introduction

4. Global Bi-Specific Antibodies Market Outlook to 2022

5. Bi-Specific Antibodies Pipeline Analysis

6. Market Dynamics

7. Current Status of Major Bi-Specific Antibodies in Pipeline

8. Trends and Developments

9. Strategic Collaborations in the Bi-Specific Antibodies Industry

10. Competitive Assessment

For more information about this report visit https://www.researchandmarkets.com/research/82tcvr/global?w=4

View Comments and Join the Discussion!